Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMpact of BrcA Status on Survival in Adjuvant Breast Cancer (IMBASSA)

NCT04012229 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Besancon as lead sponsor.

NCT NCT04012229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04012229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMpact of BrcA Status on Survival in Adjuvant Breast Cancer (IMBASSA)
Lead sponsor
Centre Hospitalier Universitaire de Besancon
Phase
Observational
Overall status
Completed
Start date
July 28, 2017
Completion date
June 21, 2018
Enrollment
2,295 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation, brca2 mutation, breast cancer